Inderal la and Aldactazide drug interactions - from FDA reports

Summary

Drug interactions are reported only by a few people who take Inderal la and Aldactazide together. This review analyzes the effectiveness and drug interactions between Inderal la and Aldactazide. It is created by eHealthMe based on reports of 3 people who take the same drugs from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on propranolol hydrochloride and hydrochlorothiazide; spironolactone (the active ingredients of Inderal la and Aldactazide, respectively), and Inderal la and Aldactazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Inderal la?

Inderal la has active ingredients of propranolol hydrochloride. It is often used in migraine. (latest outcomes from Inderal la 1,902 users)

What is Aldactazide?

Aldactazide has active ingredients of hydrochlorothiazide; spironolactone. It is often used in high blood pressure. (latest outcomes from Aldactazide 1,370 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 03, 2019

3 people who take Inderal la, Aldactazide are studied.


Number of reports submitted per year:

Inderal la and Aldactazide drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Dyspnoea (difficult or laboured respiration)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Electrocardiogram abnormal
  4. Electrocardiogram qt prolonged
  5. Erythema (redness of the skin)
  6. Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Headache (pain in head)
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Hypoxia (low oxygen in tissues)
  10. Implant infection (infection at implant site)

Most common drug interactions by gender *:

female:
  1. Dyspnoea (difficult or laboured respiration)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Electrocardiogram abnormal
  4. Electrocardiogram qt prolonged
  5. Erythema (redness of the skin)
  6. Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Headache (pain in head)
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Hypoxia (low oxygen in tissues)
  10. Implant infection (infection at implant site)
male:

n/a

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:
  1. Constipation
  2. Diabetes mellitus non insulin-dependent
  3. Dyspnoea (difficult or laboured respiration)
  4. Electrocardiogram abnormal
  5. Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Headache (pain in head)
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypoxia (low oxygen in tissues)
  9. Implant infection (infection at implant site)
  10. Nausea (feeling of having an urge to vomit)
60+:
  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  3. Blood pressure diastolic decreased
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Electrocardiogram qt prolonged
  7. Erythema (redness of the skin)

* Approximation only. Some reports may have incomplete information.


Do you take Inderal la and Aldactazide?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Inderal la and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Aldactazide and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Inderal la and Aldactazide
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Inderal la and Aldactazide (7,309 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.